BioCardia, Inc. Proceeds from Warrant Exercises
BioCardia, Inc. (BCDA) reported Proceeds from Warrant Exercises of $39.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-08-12
- BioCardia, Inc. proceeds from warrant exercises for fiscal 2025 was $5.00K.
- BioCardia, Inc. proceeds from warrant exercises for fiscal 2024 was $0.00.
- BioCardia, Inc. proceeds from warrant exercises for fiscal 2015 was $27.00K.
| Period end | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|
| 2026-06-30 | $39.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $5.00K 10-K · filed 2026-03-24 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-24 | |
| 2015-12-31 | $27.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |